Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Megestrol acetate for anorexia and cachexia.

C L Loprinzi1, P A Johnson, M Jensen

  • 1Mayo Clinic, Departments of Oncology, Rochester, MN 55905.

Oncology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health-conscious programme for appropriate use of smart devices: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2026
Same author

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Physical review letters·2026
Same author

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Physical review letters·2025
Same author

A single genotype of <i>Chlamydia psittaci</i> (ST27) found in multiple species of birds in a zoological collection in New Zealand.

New Zealand veterinary journal·2025
Same author

Psychological profiles and prescription opioid misuse, craving, and withdrawal in people with chronic pain.

European journal of pain (London, England)·2024
Same author

Propofol versus sodium thiopentone for the treatment of status epilepticus and refractory status epilepticus in dogs.

New Zealand veterinary journal·2023
Same journal

Real-World Outcomes in Acute Promyelocytic Leukemia: A 13-Year Cohort from Qatar.

Oncology·2026
Same journal

SF3A3 in Liver Hepatocellular Carcinoma: Oncogenic Role and Prognostic Significance.

Oncology·2026
Same journal

Letter to the Editor.

Oncology·2026
Same journal

FLAG-Based Versus Standard 7+3 Induction Therapy in Adults with Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.

Oncology·2026
Same journal

Longitudinal Changes in Body Weight and Body Mass Index in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors: A Retrospective Observational Study.

Oncology·2026
Same journal

Rising lung cancer burden attributable to high fasting plasma glucose in women aged ≥50 years: age-, SDI-, and BRICS-specific patterns from GBD 1990-2021.

Oncology·2026
See all related articles

Megestrol acetate shows promise in treating anorexia and cachexia by improving appetite and promoting weight gain. Further studies are ongoing to determine optimal dosage and survival benefits in at-risk patients.

Area of Science:

  • Oncology
  • Pharmacology
  • Clinical Nutrition

Background:

  • Anorexia and cachexia are significant challenges in patient care, often leading to poor outcomes.
  • Preliminary studies suggested megestrol acetate may be effective for these conditions.

Purpose of the Study:

  • To evaluate the efficacy of megestrol acetate in treating anorexia and/or cachexia.
  • To assess the antiemetic properties of megestrol acetate.
  • To investigate the dose-response relationship and survival impact of megestrol acetate.

Main Methods:

  • Randomized, placebo-controlled, double-blind clinical trials were conducted.
  • Patient populations included those with anorexia and/or cachexia.

Main Results:

Related Experiment Videos

  • Megestrol acetate demonstrated improvements in appetite for some patients.
  • Nonfluid weight gain was observed in a subset of patients.
  • The drug suggested potential antiemetic effects.

Conclusions:

  • Megestrol acetate shows potential as a treatment for anorexia and cachexia.
  • Ongoing trials are crucial for dose optimization and survival analysis.